Site IndexContact UsHome
Johns Hopkins Medicine Research

September 2003

LICENSING AND TECHNOLOGY DEVELOPMENT-
BACK

Don’t Get Tangled up in Encumbrances and Get a Handle on the Strings Attached

Scientists at JHU bring in a tremendous amount of biological materials from the outside to work with in the pursuit of scientific research. Some materials are from other Universities but the majority is from commercial sources. Just look at the mountain of boxes from companies that end up in the hallway destined for the trash or recycling. Don’t be misled. These materials, whether purchased or not, usually come with strings attached. The good news is that you can and you can keep from getting tangled if you get a handle on the encumbrances!

JHU also brings in research materials from companies under corporate sponsored research relationships. In addition, materials can be brought into JHU from companies at the request of the faculty members without such sponsored support. In both scenarios, the incoming materials are usually accompanied by incoming Material Transfer Agreements (MTAs) that stipulate the “rules of handling and transfer to others.” The sponsored research materials many times have pre-agreed MTAs that expedite the transfer.

Because companies are always looking for technology to incorporate into new products, they are particularly interested in any intellectual property that may fall out of research they sponsor. Sometimes they wish to have rights to improvements, data, derivatives, etc in return for merely providing JHU with a compound, antibody, cell line, construct, etc. They usually want and get something in return for their sponsorship investment and this is where encumbrances can originate.

It is the obligations and restrictions that JHU has agreed to or exchanges for receiving sponsored research funding or for receiving materials to be used in research which determine the extent and nature of what we can do with the research findings and the research tools that may be discovered and produced along the way.

If we agree that the company that provided funds or materials has rights to the findings, then those findings, whether tangible or not, are encumbered. This means that JHU has as least some restrictions on their freedom to operate. We may have restrictions of dissemination to third parties. We may have restrictions on licensing. We may even have restrictions on dissemination to other JHU scientists, whether collaborators or not.

There may even be encumbrances on materials that we purchase from companies. Every company sells product pursuant to their “ terms and conditions of sale.” This can be found in the fine print of the package inserts, on the catalog and web sites. Just take a look at the Invitrogen’s Limited Use Label Licenses list for an impressive list of technology patents with their use and transfer restrictions see: http://www.invitrogen.com/content.cfm?pageid=101 It’s a great source of who owns what research reagent technology.

An encumbrance can also arise from purchased reagents because some reagents contain materials that become included or co-mingled in novel biological materials made at JHU. For example a commercially available plasmid can contain the CMV promoter, owned by the University of Iowa, luciferase, owned by the University of California. A JHU investigator purchases the plasmid and inserts a novel gene into it. The investigator speaks at meetings, publishes papers and as a result the scientific community wants to use it and other companies compete to license it.

If the research was funded by NIH, JHU is obligated to disseminate to the scientific community as the Guidelines for Recipients of PHS Grant Funds require dissemination of novel materials so as to further expedite scientific knowledge and discovery. The Bayh-Dole Act of 1980, allows research institutions to retain title of PHS funded intellectual property as long as there is effort to offer discoveries, including any tangible components, to the commercial sector to stimulate product development and more timely advances destined for public use and benefit.

Because of common provisions in incoming MTAs and certain reagent Terms and Conditions of Sale, Investigators must pay close attention to any dissemination restrictions, approved fields of use, permission to use in sponsored research, and most importantly, the retention by the provider of materials of any resulting intellectual property rights before they begin to work with the materials.

Researchers obtain materials from companies, friends, colleagues, and collaborator wannabes at other Universities, usually with some restrictions. Be assured there is usually a catch! Some things we can agree to and some things we cannot.

For instance, JHU would never enter into an agreement that would restrict JHU’s academic freedom or right to publish. At LTD we try to help investigators navigate through the language that binds in an effort to de-tangle the strings that may potentially become attached to the results and outcomes of the great work performed here at JHU.

Catherine E. Vorwald, M.S.
Associate Business Development
Licensing and Technology Development
cvorwal1@jhmi.edu
Tel: 410 516-4964

Return to top of Licensing and Technology Development

 
   
September 2003 articles:

Animal Care and Use Seminars
Don't Get Tangled up in Encumbrances and Get a Handle on the Strings Attached

Conflict of Interest and Commitment Training Module
New OPC Assistant Director

Fund for Medical Discovery
 
ORA is Moving
Reminder and Update Concerning Non-Competing Grant Progress Reports
Clarification of Tobacco Policy
Tilghman Traveling Fellowship

This Month's Departmental Listings
 

Johns Hopkins Medicine
© Copyright 2003 | All Rights Reserved | Johns Hopkins University
School of Medicine
720 Rutland Avenue, Baltimore, Maryland 21205 USA